DK3626737T3 - Fremgangsmåde til at forøge produktiviteten af eukaryote celler i produktionen af rekombinant fviii - Google Patents

Fremgangsmåde til at forøge produktiviteten af eukaryote celler i produktionen af rekombinant fviii Download PDF

Info

Publication number
DK3626737T3
DK3626737T3 DK19209635.2T DK19209635T DK3626737T3 DK 3626737 T3 DK3626737 T3 DK 3626737T3 DK 19209635 T DK19209635 T DK 19209635T DK 3626737 T3 DK3626737 T3 DK 3626737T3
Authority
DK
Denmark
Prior art keywords
productivity
increasing
production
eukaryotic cells
recombinant fviii
Prior art date
Application number
DK19209635.2T
Other languages
Danish (da)
English (en)
Inventor
Peter Aizawa
Irène AGERKVIST
Original Assignee
Octapharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=45470754&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK3626737(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Octapharma Ag filed Critical Octapharma Ag
Application granted granted Critical
Publication of DK3626737T3 publication Critical patent/DK3626737T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00Preparation of peptides or proteins
    • C12P21/005Glycopeptides, glycoproteins
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745Blood coagulation or fibrinolysis factors
    • C07K14/755Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12MAPPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M1/00Apparatus for enzymology or microbiology
    • C12M1/42Apparatus for the treatment of microorganisms or enzymes with electrical or wave energy, e.g. magnetism, sonic waves
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N13/00Treatment of microorganisms or enzymes with electrical or wave energy, e.g. magnetism, sonic waves
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0018Culture media for cell or tissue culture
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0602Vertebrate cells
    • C12N5/0684Cells of the urinary tract or kidneys
    • C12N5/0686Kidney cells
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00Genetically modified cells
    • C12N2510/02Cells for production
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2511/00Cells for large scale production
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2521/00Culture process characterised by the use of hydrostatic pressure, flow or shear forces
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2527/00Culture process characterised by the use of mechanical forces, e.g. strain, vibration

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Sustainable Development (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Enzymes And Modification Thereof (AREA)
DK19209635.2T 2011-05-13 2012-05-14 Fremgangsmåde til at forøge produktiviteten af eukaryote celler i produktionen af rekombinant fviii DK3626737T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP11166071 2011-05-13
US201161489406P 2011-05-24 2011-05-24
EP12721821.2A EP2707387B1 (en) 2011-05-13 2012-05-14 A method of increasing the productivity of eucaryotic cells in the production of recombinant fviii

Publications (1)

Publication Number Publication Date
DK3626737T3 true DK3626737T3 (da) 2024-02-05

Family

ID=45470754

Family Applications (1)

Application Number Title Priority Date Filing Date
DK19209635.2T DK3626737T3 (da) 2011-05-13 2012-05-14 Fremgangsmåde til at forøge produktiviteten af eukaryote celler i produktionen af rekombinant fviii

Country Status (13)

Country Link
US (1) US9115381B2 (cg-RX-API-DMAC7.html)
EP (3) EP4353743A3 (cg-RX-API-DMAC7.html)
JP (1) JP6178786B2 (cg-RX-API-DMAC7.html)
KR (1) KR101980164B1 (cg-RX-API-DMAC7.html)
CN (1) CN103517919B (cg-RX-API-DMAC7.html)
AU (1) AU2012257736B2 (cg-RX-API-DMAC7.html)
BR (1) BR112013028006A2 (cg-RX-API-DMAC7.html)
CA (1) CA2835053C (cg-RX-API-DMAC7.html)
DK (1) DK3626737T3 (cg-RX-API-DMAC7.html)
ES (1) ES2970057T3 (cg-RX-API-DMAC7.html)
IL (1) IL229058A (cg-RX-API-DMAC7.html)
RU (1) RU2600886C2 (cg-RX-API-DMAC7.html)
WO (1) WO2012156356A1 (cg-RX-API-DMAC7.html)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6591609B2 (en) 1997-07-15 2003-07-15 New Power Concepts Llc Regenerator for a Stirling Engine
US11384378B2 (en) 2014-06-04 2022-07-12 Amgen Inc. Methods for harvesting mammalian cell cultures
CN107287265B (zh) * 2016-03-31 2018-09-14 正大天晴药业集团南京顺欣制药有限公司 一种制备重组人凝血因子ⅷ的方法
WO2020020364A1 (zh) * 2018-07-26 2020-01-30 正大天晴药业集团南京顺欣制药有限公司 一种制备重组人凝血因子ⅷ的方法
JP2025520392A (ja) * 2022-06-15 2025-07-03 ユーシービー バイオファルマ エスアールエル 細胞培養プロセス
CN120005720B (zh) * 2025-04-21 2025-08-08 深圳市茵冠生物科技有限公司 一种人工智能的细胞培养监测方法及系统

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5804420A (en) 1997-04-18 1998-09-08 Bayer Corporation Preparation of recombinant Factor VIII in a protein free medium
US6358703B1 (en) * 1998-12-10 2002-03-19 Bayer Corporation Expression system for factor VIII
AU780415B2 (en) * 1999-07-13 2005-03-17 Biovitrum Ab Stable Factor VIII compositions
EP1266006B1 (en) 2000-03-22 2005-12-07 Octagene GmbH Production of recombinant muteins of blood clotting factor viii in human cell lines
EP1720972B1 (en) * 2004-03-05 2014-01-08 DSM IP Assets B.V. Process for cell culturing by continuous perfusion and alternating tangential flow
JP2006296423A (ja) * 2005-03-24 2006-11-02 Hitachi Ltd 培養槽の制御装置及び培養装置
EP1707634A1 (en) * 2005-03-29 2006-10-04 Octapharma AG Method for isolation of recombinantly produced proteins
WO2006103298A2 (en) * 2005-04-01 2006-10-05 Novo Nordisk Health Care Ag Blood coagulation fviii analogues
EP1739179A1 (en) 2005-06-30 2007-01-03 Octapharma AG Serum-free stable transfection and production of recombinant human proteins in human cell lines
PL2343362T5 (pl) 2006-07-14 2024-12-02 Patheon Holdings I B.V. Ulepszony proces hodowli komórek
CN101490239A (zh) * 2006-07-14 2009-07-22 帝斯曼知识产权资产管理有限公司 改进的细胞培养方法
JPWO2009090787A1 (ja) * 2008-01-15 2011-05-26 東レ株式会社 生理活性ペプチドまたはタンパク質製造方法、および組換え動物細胞
AU2009264282B2 (en) * 2008-06-24 2013-04-18 Octapharma Ag A process of purifying coagulation factor VIII
RU2011110459A (ru) 2008-08-21 2012-09-27 Октафарма АГ (CH) Рекомбинантно полученный человеческий фактор viii и ix
DE102008049120A1 (de) 2008-09-26 2010-04-01 Bayer Technology Services Gmbh Verfahren zur Reduzierung von Ablagerungen bei der Kultivierung von Organismen
EP2216395A1 (en) 2009-02-09 2010-08-11 Lonza Biologics plc. Bioreactor for the cultivation of mammalian cells
US8580554B2 (en) * 2009-07-31 2013-11-12 Baxter International Inc. Method of producing a polypeptide or virus of interest in a continuous cell culture

Also Published As

Publication number Publication date
CA2835053C (en) 2020-07-07
CN103517919B (zh) 2016-11-16
KR101980164B1 (ko) 2019-05-20
JP6178786B2 (ja) 2017-08-09
JP2014513545A (ja) 2014-06-05
CA2835053A1 (en) 2012-11-22
AU2012257736A1 (en) 2013-10-10
US9115381B2 (en) 2015-08-25
EP4353743A3 (en) 2024-07-17
US20140051123A1 (en) 2014-02-20
BR112013028006A2 (pt) 2016-09-06
EP2707387B1 (en) 2019-12-25
IL229058A (en) 2017-03-30
WO2012156356A1 (en) 2012-11-22
RU2600886C2 (ru) 2016-10-27
EP3626737B1 (en) 2023-11-29
IL229058A0 (en) 2013-12-31
EP3626737A1 (en) 2020-03-25
EP4353743A2 (en) 2024-04-17
AU2012257736B2 (en) 2015-12-10
EP2707387A1 (en) 2014-03-19
RU2013155382A (ru) 2015-06-20
CN103517919A (zh) 2014-01-15
KR20140021009A (ko) 2014-02-19
ES2970057T3 (es) 2024-05-24

Similar Documents

Publication Publication Date Title
DK2686434T3 (da) Fremgangsmåde til reduktion af viskositet i saccharificeringsproces
DK3013964T3 (da) Sammensætninger til indføring af rna i celler
DK3064508T4 (da) Fremgangsmåde til fremstilling af rekombinant vwf med høj molekylevægt i cellekultur
SG10201601100RA (en) Process and structures for fabrication of solar cells
EP2695199A4 (en) SLIDING PHOTOVOLTAIC MODULES
DK2970423T3 (da) Interleukin-2 muteiner for udvidelsen af t-regulatoriske celler
DK3653698T3 (da) Automatiseret system til fremstilling af inducerede pluripotente stamceller eller differentierede celler
GB2498879B (en) Electrodeposition methods for fabrication of photovoltaic devices
DK2739293T3 (da) Fremgangsmåder og sammensætninger til frembringelse af vaccinavirus
DK2736837T3 (da) Fremgangsmåde til fremstilling af nanosiliciumtråde
PL2884999T3 (pl) Sposób i kompozycje do immunoterapii komórkowej
DK2890836T3 (da) Fremgangsmåder i forbindelse med modulatorer af eukaryotiske celler
MY156847A (en) Solar cell and method of manufacture thereof, and solar cell module
DK2533895T3 (da) Fremgangsmåde til fremstilling af hydrogeneret biodiesel
EP3719852C0 (en) SOLAR CELL
DE112012001603A5 (de) Photovoltaik-Indach
BR112013028289A2 (pt) sistemas solares híbridos e métodos de produção
EP3014659A4 (en) Formation of metal structures in solar cells
DK2685554T3 (da) Siliciumdioxid-solcelle
DK3626737T3 (da) Fremgangsmåde til at forøge produktiviteten af eukaryote celler i produktionen af rekombinant fviii
DK3505634T3 (da) Fremgangsmåde til fremstilling af rekombinante allergener af høj kvalitet i en plante
DK2825633T3 (da) Fremgangsmåde til dyrkning af E. coli-celler til høj densitet
IL237607A0 (en) Photovoltaic solar cell and method for producing a photovoltaic solar cell
DK2935138T3 (da) Fremgangsmåde til glasfremstilling med anvendelse af elektrisk smeltning
DK2737060T3 (da) Fremgangsmåde til fremstilling af retrovirale partikler, der er nyttige for transduktion af eukaryotiske celler